Preventing Falls in Older Adults With Cognitive Frailty
Launched by UNIVERSITY OF BRITISH COLUMBIA · Feb 25, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at ways to help older adults who are at risk of falls due to cognitive frailty. Specifically, it aims to find out if a home-based exercise program combined with behavioral change techniques can significantly reduce the number of falls experienced by these individuals compared to a standard health education program. The trial will involve older adults aged 70 to 89 years who live in the Greater Vancouver area, have had a fall in the past year, and have some cognitive concerns, but do not have dementia.
To participate, individuals need to be able to walk independently, have access to the internet, and be able to safely engage in exercise. Participants will follow the study for 18 months, during which they will be guided through the exercise program and supported in making changes to their daily routines to help prevent falls. It's important to note that people with certain medical conditions, such as dementia or those who already engage in regular strength and balance training, will not be eligible for this study. This trial is not yet recruiting participants, but it aims to provide valuable information on how to keep older adults safer and more independent in their homes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • We will include individuals who: 1) are aged 70 to 89 years\*; 2) live in Greater Vancouver; 3) are community-dwelling (i.e., not residing in a nursing home or extended care unit); 4) experienced a non-syncopal fall in the prior 12 months; 5) scored \< 9/12 on the SPPB; 6) have subjective cognitive complaints based on interview; 7) scored 18-25/30 on the MoCA; 8) are able to walk independently; use of cane is acceptable; 9) are able to safely engage in exercise as indicated by the Physical Activity Readiness Questionnaire Plus (PAR-Q+) and confirmed by their physician; 10) have internet at home; and 11) are able to provide written informed consent.
- • The age maximum of 89 was set due to the increased risk of significant adverse health outcomes cognitively frail older adults face. As this population has an increased risk of falls, functional disability with loss of independence, hospitalization, and death, setting an age maximum aims to increase the likelihood that participants will be able to complete the 18-month study without interruptions due to health complications. This age limit has been reviewed and approved by CIHR.
- Exclusion Criteria:
- • We will exclude those who are: 1) diagnosed with dementia, as measured by a Clinical Dementia Rating (CDR) score above 0.5, a neurodegenerative disease, or stroke; 2) self-report engaging in strength training and/or balance training exercises \> 2 times per week, in the prior 3 months; or 3) unable to understand, speak, and read English proficiently.
About University Of British Columbia
The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vancouver, British Columbia, Canada
Patients applied
Trial Officials
Teresa Liu-Ambrose, PhD
Principal Investigator
University of British Columbia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported